BIOLOGICS MANUFACTURING CENTRE (BMC) INC.
$172,791,000.00 CAD
- Department
- National Research Council Canada
- Program
- Biologics Manufacturing Centre
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- December 19, 2022 – March 31, 2033
- Reference
- nrc-cnrc:172-2022-2023-Q4-00003
Published purpose
NRC provides contribution funding for the maintenance and operation of the BMC facility in a constant Good Manufacturing Practice (GMP)-readiness state to respond to pandemic and other health emergencies, ensuring surety of domestic vaccines and other biologics for Canadians.
In plain English AI-generated
This contribution funds the maintenance and operation of the Biologics Manufacturing Centre in Canada to keep it ready for Good Manufacturing Practice (GMP) production of vaccines and biologics during health emergencies.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.